Sample size for replicate design partial AUC [Power / Sample Size]

posted by AngusMcLean – USA, 2014-06-25 04:11 (3960 d 19:17 ago) – Posting: # 13137
Views: 19,092

We have early partial AUC data from a completed study and the CV (%) for the early partial AUC intra­subject between formulation variance is 30.5%. The reason we have measured the partial AUC is that we are required by the FDA to submit BE data on the partial AUC metric when performing a pivotal BE study.

The question arises if we should use a replicate study design. I am thinking "yes" and thinking in terms of a full replicate design comparing test and reference formulations.


I am thinking in terms of estimating sample size and power. Are there Tables available for estimating the sample size and power of such study designs I have information here only for nonrepliciate BE study designs.

Comments are most welcome on this topic,

Angus

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,673 registered users;
91 visitors (0 registered, 91 guests [including 2 identified bots]).
Forum time: 23:29 CEST (Europe/Vienna)

There are two possible outcomes: if the result confirms the
hypothesis, then you’ve made a measurement. If the result is
contrary to the hypothesis, then you’ve made a discovery.    Enrico Fermi

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5